Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Marie Robin"'
Autor:
Guillermo Ortí, Luuk Gras, Nienke Zinger, Maria Chiara Finazzi, Katja Sockel, Marie Robin, Edouard Forcade, Daniele Avenoso, Nicolaus Kröger, Jürgen Finke, Aleksandar Radujkovic, Mathilde Hunault‐Berger, Wilfried Schroyens, Tsila Zuckerman, Jean Henri Bourhis, Yves Chalandon, Adrian Bloor, Rik Schots, Liesbeth C. de Wreede, Joana Drozd‐Sokolowska, Kavita Raj, Nicola Polverelli, Tomasz Czerw, Juan Carlos Hernández‐Boluda, Donal McLornan, Ibrahim Yakoub‐Agha
Publikováno v:
American journal of hematology
Allogeneic hematopoietic cell transplant (allo-HCT) provides the only potential route to long-term remission in patients diagnosed with blast phase transformation of mye-loproliferative neoplasm (BP-MPN). We report on a large, retrospective European
Autor:
A. Varoquaux, L. Castillo, M. Tassart, R. Jankowski, Emmanuelle Uro-Coste, F. Massip, L. Brugel, S Testelin, René-Jean Bensadoun, Olivier Mauvais, C. Bach, P. Herman, Christian-Adrien Righini, Laurent Gilain, Xavier Dufour, T. Mom, L. Laccoureye, E. Baudin, Justin Michel, Ludovic Le Taillandier de Gabory, G. Moulin, D. de Raucourt, C. Ferron, Juliette Thariat, R. Breheret, J.-M. Badet, V. Darrouzet, Bruno Devauchelle, T. Radulesco, Bertrand Baujat, V. Strunski, G. Poissonnet, Thomas Radulesco, Jean-Claude Merol, Renaud Garrel, C. Borel, A. Cosmidis, Odile Casiraghi, Dominique Chevalier, E. Serrano, Caroline Even, J.-C. Merol, P. Demez, L. Geoffrois, N. Fakhry, J.-P. Lavieille, A. Banal, J. Lacau St Guily, S. Duflo, J.-P. Bessède, B. Baujat, Marie Christine Kaminsky, F. Chabolle, Sebastien Albert, Roch Giorgi, O. Sterkers, N. Sarroul, Vianney Bastit, D. Blanchard, P. Lang, E. de Monès, P. Breton, G. Dolivet, R. Garrel, Sébastien Vergez, B. Toussaint, Anne Sudaka, A. Giovanni, G. Noel, P. Hofman, A. Bozorg-Grayeli, O. Malard, M. Housset, E. Lartigau, P. Ceruse, Valérie Costes-Martineau, C. Bertolus, Cécile Badoual, G. Andry, T. Van den Abbeele, F. Kolb, S. Faivre, F. Floret, P. Dessi, M. Juliéron, Nicolas Fakhry, J. Michel, Louis Crampette, Francois Mouawad, O. Choussy, Philippe Schultz, S. Hans, Marine Lefevre, L. Gilain, Emile Reyt, Sylvain Morinière, Philippe Herman, G. Valette, Béatrix Barry, A. Timochenko, Gilles Poissonnet, Antoine Moya-Plana, F. Veillon, S. Vergez, A. Coste, Franck Jegoux, E. Cassagnau, Christine Bach, Y. Marie Robin, B. Guerrier, E. Uro Coste, X. Leroy, Valérie Costes, Olivier Malard, F. Rolland, F. Dubrulle, A.C. Baglin, L. de Gabory, B. Ruhin, A. Girod, G. Calais, Laurie Saloner Dahan, Emmanuel Babin, J.C. Chobaut, Michel Wassef, Benjamin Lallemant, Jean-Michel Prades, C.-A. Righini
Publikováno v:
EJSO-European Journal of Surgical Oncology
EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, 47 (6), pp.1376-1383. ⟨10.1016/j.ejso.2020.11.123⟩
EJSO-European Journal of Surgical Oncology, 2021, 47 (6), pp.1376-1383. ⟨10.1016/j.ejso.2020.11.123⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, ⟨10.1016/j.ejso.2020.11.123⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, 47 (6), pp.1376-1383. ⟨10.1016/j.ejso.2020.11.123⟩
EJSO-European Journal of Surgical Oncology, 2021, 47 (6), pp.1376-1383. ⟨10.1016/j.ejso.2020.11.123⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2020, ⟨10.1016/j.ejso.2020.11.123⟩
International audience; Background: To describe the characteristics of the largest European study of MEC of salivary glands and to determine the prognostic factors for overall and disease free survival.Patients and methods: Patients with MEC were pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91024466ed16727db6fbb632f8700055
https://hal.archives-ouvertes.fr/hal-03049061
https://hal.archives-ouvertes.fr/hal-03049061
Autor:
Jean-Baptiste Bossard, Société Francophone de Greffe de Moelle et de Thérapie Cellulaire, Mohamad Mohty, Florence Beckerich, Marie-Thérèse Rubio, Patrice Chevallier, Jérôme Cornillon, Fiorenza Barraco, Federico Garnier, Marie Robin, Alain Duhamel, Gandhi Damaj, Corentin Orvain, Jean-Baptiste Beuscart, Ibrahim Yakoub-Agha, Mathieu Meunier, Thomas Cluzeau, Amandine Charbonnier, Patrice Ceballos, Didier Blaise, Carmen Botella-Garcia, Jean-Jacques Kiladjian, Jacques-Olivier Bay, Tony Marchand
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2021, 96 (1), pp.80-88. ⟨10.1002/ajh.26034⟩
American Journal of Hematology, Wiley, 2021, 96 (1), pp.80-88. ⟨10.1002/ajh.26034⟩
The value of pretransplant splenectomy in patients with myelofibrosis (MF) is subject to debate, since the procedure may preclude subsequent allogeneic hematopoietic cell transplantation (allo-HCT). To determine the impact of pretransplant splenectom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49113b46f2ebd0e35ede9bc08654603b
https://hal.uca.fr/hal-03089653
https://hal.uca.fr/hal-03089653
Autor:
Raynier Devillier, Yves Beguin, Sara Villar, Jacques-Olivier Bay, David Beauvais, Marie Robin, Nicole Raus, Amandine Charbonnier, Stéphanie Nguyen, Marie-Thérèse Rubio, Patrice Chevallier, Xavier Poiré, Remy Dulery, Sylvain Chantepie, Patrice Ceballos, Sylvie Chevret, Jean-Henri Bourhis, Michael Loschi, Edouard Forcade
Publikováno v:
Blood. 138:1844-1844
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only curative therapy in patients with primary or secondary myelofibrosis. Ruxolitinib, a JAK-inhibitor, has been approved in myelofibrosis patients and is effective to
Autor:
Didier Blaise, Gerhard Ehninger, Arnold Ganser, Martin Gramatzki, Dietrich W. Beelen, Anja van Biezen, Michael Schleuning, Jakob Passweg, Marie Robin, Liisa Volin, Paolo Emilio Alessandrino, Theo de Witte, Dietger Niederwieser, Ghulam J. Mufti, Hendrik Veelken, Renate Arnold, Liesbeth C. de Wreede, Jürgen Finke, Ibrahim Yakoub-Agha, Jan J. Cornelissen, Christoph Schmid, Montserrat Rovira, Noel Milpied, N Kröger, Johan Maertens, Lothar Kanz
Publikováno v:
Haematologica, 103, 2, pp. 237-245
Haematologica, 103(2), 237-245. Ferrata Storti Foundation
Haematologica
Haematologica, Ferrata Storti Foundation, 2018, 103 (2), pp.237-245. ⟨10.3324/haematol.2017.168716⟩
Haematologica, 2018, 103 (2), pp.237-245. ⟨10.3324/haematol.2017.168716⟩
Haematologica, 103, 237-245
Haematologica, 103(2), 237-245
Haematologica, 103(2), 237-245. Ferrata Storti Foundation
Haematologica
Haematologica, Ferrata Storti Foundation, 2018, 103 (2), pp.237-245. ⟨10.3324/haematol.2017.168716⟩
Haematologica, 2018, 103 (2), pp.237-245. ⟨10.3324/haematol.2017.168716⟩
Haematologica, 103, 237-245
Haematologica, 103(2), 237-245
No standard exists for the treatment of myelodysplastic syndrome relapsing after allogeneic stem cell transplantation. We performed a retrospective registry analysis of outcomes and risk factors in 698 patients, treated with different strategies. The
Autor:
Kai Hübel, X Poire, Georg Franke, Peter Dreger, Ronald Brand, Thomas Weber, Ruzena Uddin, Stefano Guidi, Nicolaus Kröger, Theo de Witte, Giorgio Lambertenghi Deliliers, Guido Kobbe, Uwe Platzbecker, Matthias Stelljes, Liisa Volin, Christof Scheid, Simona Iacobelli, Andreas Günther, Marleen van Os, Wolfgang A. Bethge, Dominik Heim, Marie Robin, Francesco Onida, Boris V. Afanasyev, Massimo Pini
Publikováno v:
Journal of Clinical Oncology, 35(19), 2157
Journal of Clinical Oncology, 35, 19, pp. 2157-2164
Journal of Clinical Oncology, 35, 2157-2164
Journal of Clinical Oncology, 35, 19, pp. 2157-2164
Journal of Clinical Oncology, 35, 2157-2164
Purpose To compare a reduced-intensity conditioning regimen (RIC) with a myeloablative conditioning regimen (MAC) before allogeneic transplantation in patients with myelodysplastic syndrome (MDS) within a randomized trial. Patients and Methods Within
Autor:
Delcampe A, Anne Huynh, Felipe Suarez, Marie Robin, Jordan Gauthier, Stephane Vigouroux, Noel-Jean Milpied, Marie T Rubio, Leonardo Magro, Oumadely R, Stéphanie Nguyen, J.-H. Dalle, M Richet, Ibrahim Yakoub-Agha, Fagot T
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Bone Marrow Transplantation, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Bone Marrow Transplantation, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Chronic GvHD-related keratoconjunctivitis sicca (cGvHD-related KCS) can significantly alter the quality of life of patients after allogeneic hematopoietic stem cell transplantation. The aim of this work was to assess the efficacy and tolerability of
Autor:
Marie Robin, Victoria Potter, Henrik Sengeloev, Guido Kobbe, Didier Blaise, Ellen Meijer, Sheree Hazelaar, Arnold Ganser, Gérard Socié, Yves Chalandon, Peter Dreger, Ibrahim Yakoub-Agha, Dietger Niederwieser, Jürgen Finke, Dirk-Jan Eikema, Francesco Onida, Johan Maertens, Hendrik Veelken, Noel Milpied, Christian Koenecke, Nicolaus Kröger, Dietrich W. Beelen, Martin Bornhaeuser, Per Ljungman, Maija Itälä-Remes
Introduction The only curative treatment approach for patients with myelodysplastic syndromes (MDS) is allogeneic hematopoietic stem cell transplantation (HSCT), but disease relapse after transplantation is a major concern. Predictors for disease out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6ebada494370d903c14ab5afcee817
https://doi.org/10.1112/blood-2018-99-115981
https://doi.org/10.1112/blood-2018-99-115981
Autor:
Anna Baud, Philippe Saudemont, Michel Salzet, Yves Marie Robin, Mélissa Pottier, Benoit Fatou, Michael Ziskind, Dominique Tierny, Julia Balog, Isabelle Fournier, Kevin Minier, Jusal Quanico, Quentin Pascal, Zoltan Takats, Cristian Focsa
Publikováno v:
Cancer Cell
Cancer Cell, Elsevier, 2018, 34 (5), pp.840-851.e4. ⟨10.1016/j.ccell.2018.09.009⟩
Cancer Cell, 2018, 34 (5), pp.840-851.e4. ⟨10.1016/j.ccell.2018.09.009⟩
Cancer Cell, Elsevier, 2018, 34 (5), pp.840-851.e4. ⟨10.1016/j.ccell.2018.09.009⟩
Cancer Cell, 2018, 34 (5), pp.840-851.e4. ⟨10.1016/j.ccell.2018.09.009⟩
International audience; Histopathological diagnosis of biopsy samples and margin assessment of surgical specimens are challenging aspects in sarcoma. Using dog patient tissues, we assessed the performance of a recently developed technology for fast e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbd957eb9465fa7ad02e5aa594be405
https://www.hal.inserm.fr/inserm-02940768/file/1-s2.0-S1535610818304239-main.pdf
https://www.hal.inserm.fr/inserm-02940768/file/1-s2.0-S1535610818304239-main.pdf
Autor:
Thomas Luft, Arnon Nagler, Charles Craddock, Patrice Chevallier, Nicolaus Kröger, Ibrahim Yakoub-Agha, Juergen Finke, Marie Robin, Myriam Labopin, Henrik Sengeløv, Didier Blaise, Michael Hallek, Jean Bourhis, Mohamad Mohty
Publikováno v:
Haematologica. 101:879-883
Disease relapse is the most common cause of treatment failure after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndromes, yet treatment options for such patients remain extremely limited. Azacitidine is an imp